These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus. Caviezel F; Lepore G; Maglio ML; Croci M; Comi G; Morricone L Acta Diabetol Lat; 1989; 26(2):133-45. PubMed ID: 2781979 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic stimulation of HGH in diabetes mellitus and in obesity. Gragnoli G; Palazzuoli V; Favilli R; Tanganelli I; Migliarese G Acta Diabetol Lat; 1977; 14(3-4):137-43. PubMed ID: 605744 [TBL] [Abstract][Full Text] [Related]
10. Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone. Barnes AJ; Kohner EM; Johnston DG; Alberti KG Lancet; 1985 Jun; 1(8444):1465-8. PubMed ID: 2861408 [TBL] [Abstract][Full Text] [Related]
11. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus. Krassowski J; Jeske W; Zgliczyński S Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575 [TBL] [Abstract][Full Text] [Related]
12. [Diabetic retinopathy and growth hormone secretion in 39 non insulin-dependant diabetic patients]. Hautecouverture M; Monchi A; Tchobroutsky G; Assan R; Slama G; Derot M Nouv Presse Med; 1973 Jul; 2(27):1817-22. PubMed ID: 4719844 [No Abstract] [Full Text] [Related]
13. [Proliferative retinopathy in growth-onset diabetes and in maturity-onset diabetes (author's transl)]. Fischer F Wien Klin Wochenschr; 1978 Jun; 90(13):449-52. PubMed ID: 664712 [TBL] [Abstract][Full Text] [Related]
14. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Gerich JE Scand J Gastroenterol Suppl; 1986; 119():154-7. PubMed ID: 2876500 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of immunoreactive insulin and human growth hormone release by administration of arginine in patients with diabetic retinopathy. Waldhäusl W Acta Endocrinol (Copenh); 1972 Aug; 70(4):719-30. PubMed ID: 5068400 [No Abstract] [Full Text] [Related]
16. Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Salardi S; Cacciari E; Ballardini D; Righetti F; Capelli M; Cicognani A; Zucchini S; Natali G; Tassinari D Diabetes; 1986 Jul; 35(7):832-6. PubMed ID: 3721066 [TBL] [Abstract][Full Text] [Related]
17. Effect of insulin on growth-hormone secretion in juvenile diabetics. Hansen AP Lancet; 1972 Aug; 2(7774):432-3. PubMed ID: 4115254 [No Abstract] [Full Text] [Related]
18. Is growth hormone associated with diabetic retinopathy? Hattori N; Moridera K; Ishihara T; Hino M; Ikekubo K; Kurahachi H J Diabetes Complications; 1993; 7(1):12-4. PubMed ID: 8481545 [TBL] [Abstract][Full Text] [Related]
19. HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes. Gray RS; Starkey IR; Rainbow S; Kurtz AB; Abdel-Khalik A; Urbaniak S; Elton RA; Duncan LJ; Clarke BF Br J Ophthalmol; 1982 May; 66(5):280-5. PubMed ID: 7074002 [TBL] [Abstract][Full Text] [Related]
20. The role of growth hormone in the development of diabetic retinopathy. Alzaid AA; Dinneen SF; Melton LJ; Rizza RA Diabetes Care; 1994 Jun; 17(6):531-4. PubMed ID: 8082520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]